Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...

During the Chicago Marathon, thousands of runners were short of breath at the end of the grueling race. But one runner took on 26.2 with just 30 percent lung capacity. Eleven years ago, Russell ...

US patients with chronic obstructive pulmonary disease (COPD) managed in primary care settings have high exacerbations, symptoms, and treatment burdens, according to an analysis of electronic health ...

The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and advocacy organization. Founded in 1997 in collaboration with the U.S. National ...

For some patients with chronic obstructive pulmonary disease (COPD), summer can be one of the most stressful times of the year. Not only is allergy season in full swing, but rising temperatures and ...

Please provide your email address to receive an email when new articles are posted on . Patients with COPD underwent the Mini-International Neuropsychiatric Interview. Receipt of mental health ...

This development marks a crucial step forward in SMSbiotech's efforts to address this debilitating respiratory condition. The Phase I trial, conducted in Australia, will be the first human trial of ...

International Journal for Quality in Health Care, Vol. 31, No. 9 (November 2019), pp. G126-G132 (7 pages) Objective Access to primary care (PC) is vital, but complex to define and compare between ...

Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype Following recent ...